Skip to main content
NCBI home page
Japanese Journal of Cancer Research : Gann logoLink to Japanese Journal of Cancer Research : Gann
. 1994 Oct;85(10):1005–1014. doi: 10.1111/j.1349-7006.1994.tb02898.x

K‐ras and p53 Alterations in Genomic DNA and Transcripts of Human Pancreatic Adenocarcinoma Cell Lines

Hirofumi Suwa 1,2, Tsunehiro Yoshimura 1,2, Nozomi Yamaguchi 3, Kazunori Kanehira 1, Tadao Manabe 2, Masayuki Imamura 2, Hiroshi Hiai 1, Manabu Fukumoto 1,✉
PMCID: PMC5919355  PMID: 7961102

Abstract

We analyzed 15 human pancreatic adenocarcinoma cell lines for alterations of the K‐ras and the p53 genes and their transcripts. In 11 cell lines (73.3%), point mutations of the K‐ras gene were found at codon 12 in exon 1. In 9 cell lines one allele was mutated and the other was wild type, and both the alleles were expressed into mRNA. In one cell line both alleles of codon 12 were mutated to TGT and GTT, respectively, hut only TGT was transcribed into mRNA. Alterations in mRNA of the p53 gene were detected in 10 cell lines (66.7%). Analysis of the genomlc sequence of the p53 gene revealed that the alterations consisted of 6 cases of base pair substitutions and 1 case of 1‐bp deletion in evolutionarily conserved exons 5 to 8, 2 cases of splicing mutations in exon 4, and 1 case of novel deletion from exons 2 to 9. In 14 cell lines (93.3%), alterations were identified in the K‐ras or p53 gene. Of these, 4 cell lines harbored K‐ras mutations without p53 alteration, whereas 3 cell lines exhibited p53 alterations without K‐ras mutation. Thus, it is suggested that activation of the K‐ras gene and inactivation of the p53 gene are strongly and cooperatively associated with pancreatic carcinogenesis.

Keywords: K‐ras, p53, Genomic DNA, mRNA, Mutation

Full Text

The Full Text of this article is available as a PDF (987.9 KB).

REFERENCES

  • 1. ) Poston , G. J. , Gillespie , J. and Guillou , P. J.Biology of pancreatic cancer . Gut , 32 , 800 – 812 ( 1991. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. ) Warshaw , A. L. and Castillo , C. F.Pancreatic carcinoma . N. Engl J. Med. , 326 , 455 – 465 ( 1992. ). [DOI] [PubMed] [Google Scholar]
  • 3. ) Ruggeri , B. , Zhang , S.‐Y. , Caamano , J. , Dirado , M. , Flynn , S. D. and Klein‐Szanto , A. J. P.Human pancreatic carcinomas and cell lines reveal frequent and multiple alterations in the p53 and Rb‐1 tumor‐suppressor genes . Oncogene , 7 , 1503 – 1511 ( 1992. ). [PubMed] [Google Scholar]
  • 4. ) Bishop , J. M.Molecular themes in oncogenesis . Cell , 64 , 235 – 248 ( 1991. ). [DOI] [PubMed] [Google Scholar]
  • 5. ) Hruban , R. H. , Van Mansfeld , A. D. M. , Offerhaus , G. J. A. , Van Weering , D. H. J. , Allison , D. C. , Goodman , S. N. , Kensler , T. W. , Bose , K. K. , Cameron , J. and Bos , J. L.K‐ras oncogene activation in adenocarcinoma of the human pancreas . Am. J. Pathol , 143 , 545 – 554 ( 1993. ). [PMC free article] [PubMed] [Google Scholar]
  • 6. ) Almoguera , C. , Shibata , D. , Forrester , K. , Martin , J. and Perucho , M.Most human carcinoma of the exocrine pancreas contain mutant c‐K‐ras genes . Cell , 53 , 549 – 554 ( 1988. ). [DOI] [PubMed] [Google Scholar]
  • 7. ) Smit , V. T. , Boot , A. J. , Smits , A. A. , Fleuren , G. J. , Cornelisse , C. J. and Bos , J. L.K‐ras codon 12 mutations occur very frequently in pancreatic adenocarcinoma . Nucleic Acids Res. , 16 , 7773 – 7782 ( 1988. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. ) Nagata , Y. , Abe , M. , Motoshima , K. , Nakayama , E. and Shiku , H.Frequent glycine‐to‐aspartic acid mutations at codon 12 of c‐Ki‐ras gene in human pancreatic cancer in Japanese . Jpn. J. Cancer Res. , 81 , 135 – 140 ( 1990. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. ) Cerny , W. L. , Mangold , K. A. and Scarpelli , D. G.K‐ras mutation is an early event in pancreatic duct carcino‐genesis in the Syrian golden hamster . Cancer Res. , 52 , 4507 – 4513 ( 1992. ). [PubMed] [Google Scholar]
  • 10. ) Tsutsumi , M. , Kondoh , S. , Noguchi , O. , Horiguchi , K. , Kobayashi , E. , Okita , S. , Ohashi , K. , Honoki , K. , Tsujiuchi , T. and Konishi , Y.K.‐ras gene mutation in early ductal lesions induced in a rapid production model for pancreatic carcinomas in Syrian hamsters . Jpn. J. Cancer Res. , 84 , 1101 – 1105 ( 1993. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. ) Shibata , D. , Capella , G. and Perucho , M.Mutational activation of the c‐K‐ras gene in human pancreatic carci‐ noma . Baillieres Clin. Gastroenterol , 4 , 151 – 169 ( 1990. ). [DOI] [PubMed] [Google Scholar]
  • 12. ) Nigro , J. M. , Baker , S. J. , Preisinger , A. C. , Jessup , J. M. , Hostetter , R. , Clesry , K. , Bigner , S. H. , Davidson , N. , Baylin , S. , Devilee , P. , Glover , T. , Collins , F. S. , Weston , A. , Modali , R. , Harris , C. C. and Vogelstein , B.Mutations in the p53 gene occur in diverse human tumour types . Nature , 342 , 705 – 708 ( 1989. ). [DOI] [PubMed] [Google Scholar]
  • 13. ) Hollstein , M. , Sidransky , D. , Vogelstein , B. and Harris , C. C.p53 mutations in human cancers . Science , 253 , 49 – 52 ( 1991. ). [DOI] [PubMed] [Google Scholar]
  • 14. ) Barton , C. M. , Staddon , S. L. , Hughes , C. M. , Hall , P. A. , O'Suuivan , C. , Kloppel , G. , Theis , B. , Russell , R. C. G. , Neoptolemos , J. , Williamson , R. C. N. , Lane , D. P. and Lemoine , N. R.Abnormalities of the p53 tumor suppressor gene in human pancreatic cancer . Br. J. Cancer , 64 , 1076 – 1082 ( 1991. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. ) Kalthoff , H. , Schmiegel , W. , Roeder , C. , Kasche , D. , Schmidt , A. , Lauer , G. , Thiele , H. G. , Honold , G. , Pantel , K. , Riethmuller , G. , Scherer , E. , Maurer , J. , Maacke , H. and Deppert , W.p53 and K‐RAS alterations in pancreatic epithelial cell lesions . Oncogene , 8 , 289 – 298 ( 1993. ). [PubMed] [Google Scholar]
  • 16. ) Scarpa , A. , Capelli , P. , Mukai , K. , Zamboni , G. , Oda , T. , Lacono , C. and Hirohashi , S.Pancreatic adenocarcinoma frequently show p53 gene mutations . Am. J. Pathol , 142 , 1534 – 1543 ( 1993. ). [PMC free article] [PubMed] [Google Scholar]
  • 17. ) Yamaguchi , N. , Yamamura , Y. , Koyama , K. , Ohtsuji , E. , Imanishi , J. and Ashihara , T.Characterization of new human pancreatic cancer cell lines which propagate in a protein‐free chemically denned medium . Cancer Res. , 50 , 7008 – 7014 ( 1990. ). [PubMed] [Google Scholar]
  • 18. ) Fukumoto , M. , Estensen , R. , Sha , L. , Oakley , G. J. , Twiggs , L. B. , Adcock , L. L. , Carson , L. F. and Roninson , I. B.Association of Ki‐ras with amplified DNA sequences, detected in human ovarian carcinomas by a modified in‐gel renaturation assay . Cacner Res. , 49 , 1693 – 1697 ( 1988. ). [PubMed] [Google Scholar]
  • 19. ) Arao , S. , Suwa , H. , Mandai , M. , Tashiro , H. , Miyazaki , K. , Okamura , H. , Nomura , H. , Hiai , H. , and Fukumoto , M.Expression of multidrug resistance gene and localization of P‐glycoprotein in human primary ovarian cancer . Cancer Res. , 54 , 1355 – 1359 ( 1994. ). [PubMed] [Google Scholar]
  • 20. ) Vincent , S. , Marty , L. and Fort , P.S26 ribosomal protein RNA: an invariant control for gene regulation experiments in eucaryotic cells and tissues . Nucleic Acids Res. , 21 , 1498 ( 1993. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21. ) Miwa , H. , Kita , K. , Saya , H. , Ohtsuji , A. , Masuya , M. , Nishii , K.Morita , N. , Takakura , N. , Ohishi , K. , Nasu , K. , Nakase , K. and Shirakawa , S.Structural alterations of the p53 gene in human leukemias . Leuk. Res. , 16 , 1105 – 1112 ( 1992. ). [DOI] [PubMed] [Google Scholar]
  • 22. ) Vojtêêek , B. , Bártek , J. , Midgley , C. A. and Lane , D. P.An immunohistochemical analysis of the human nuclear phosphoprotein p53 . J Immunol. Methods , 151 , 237 – 244 ( 1992. ). [DOI] [PubMed] [Google Scholar]
  • 23. ) Bos , J. L.The ras gene family and human carcinogenesis . Mutat. Res. , 195 , 255 – 271 ( 1988. ). [DOI] [PubMed] [Google Scholar]
  • 24. ) Shiraishi , M. , Noguchi , M. , Shimosato , Y. and Sekiya , T.Amplification of protooncogenes in surgical specimen of human lung carcinomas . Cancer Res. , 49 , 6474 – 6479 ( 1989. ). [PubMed] [Google Scholar]
  • 25. ) Taya , Y. , Hosogai , K. , Hirohashi , S. , Shimosato , Y. , Tsuchiya , R. , Tsuchida , N. , Fushimi , M. , Sekiya , T. and Nishimura , S.A novel combination of K‐ras and myc amplification accompanied by point mutational activation of K‐ras in a human lung cancer . EMBO J. , 3 , 2943 – 2946 ( 1984. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. ) Winter , E. , Yamamoto , F. , Almoguera , C. and Perucho , M.A method to detect and characterize point mutations in transcribed genes: amplification and overexpression of the mutant c‐Ki‐ras allele in human tumor cells . Proc. Natl. Acad. Scl USA , 82 , 7575 – 7579 ( 1985. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. ) Slebos , R. J. C. , Habets , G. O. M. , Evers , S. G. , Mooi , W. J. and Rodenhuis , S.Allele‐specific detection of K‐ras oncogene expression in human non‐small‐cell lung carcinomas . Int. J. Cancer , 48 , 51 – 56 ( 1991. ). [DOI] [PubMed] [Google Scholar]
  • 28. ) Levine , A. J. , Momand , J. and Finlay , C. A.The p53 tumor suppressor gene . Nature , 351 , 453 – 456 ( 1991. ). [DOI] [PubMed] [Google Scholar]
  • 29. ) Malkin , D. , Li , F. P. , Strong , L. C. , Fraumeni , J. F. , Nelson , C. E. , Kim , D. H. , Kassel , J. , Gryka , M. A. , Bischoff , F. Z. , Tainsky , M. A. and Freind , S. H.Germ line p53 mutations in a familial syndrome of breast cancer, sarcoma and other neoplasms . Science , 250 , 1233 – 1238 ( 1990. ). [DOI] [PubMed] [Google Scholar]
  • 30. ) Sameshima , Y. , Akiyama , T. , Mori , N. , Mizoguchi , H. , Toyoshima , K. , Sugimura , T. , Terada , M. and Yokota , J.Point mutation of the p53 gene resulting in splicing inhibition in small cell lung carcinoma . Biochem. Biophys. Res. Commun. , 173 , 697 – 703 ( 1990. ). [DOI] [PubMed] [Google Scholar]
  • 31. ) Mitsudomi , T. , Steinberg , S. M. , Nau , M. M. , Carbone , D. , D'Amico , D. , Bodner , S. , Oie , H. K. , Linnoila , R. L. , Mulshine , J. L. , Minna , J. D. and Gazder , A. F.p53 gene mutations in non‐small‐cell lung cancer cell lines and their correlation with the presence of ras mutations and clinical features . Oncogene , 7 , 171 – 180 ( 1992. ). [PubMed] [Google Scholar]
  • 32. ) Sakai , E. and Tsuchida , N.Most human squamous cell carcinoma in the oral cavity contain mutated p53 tumor‐suppressor genes . Oncogene , 7 , 927 – 933 ( 1992. ). [PubMed] [Google Scholar]
  • 33. ) Bodner , S. M. , Minna , J. D. , Jensen , S. M. , D'Amico , D. , Carbone , D. , Mitsudomi , T. , Fedorko , J. , Buchhagen , D. L. , Nau , M. M. , Gazdar , A. F. and Linnoila , R. I.Expression of mutant p53 proteins in lung cancer correlates with the class of p53 gene mutations . Oncogene , 7 , 743 – 749 ( 1992. ). [PubMed] [Google Scholar]
  • 34. ) Toguchida , J. , Yamaguchi , T. , Ritchie , B. , Beauchamp , R. L. , Dayton , S. H. , Herrera , G. E. , Yamamuro , T. , Kotoura , Y. , Sasaki , M. S. , Little , J. B. , Weichselbaum , R. R. , Ishizaki , K. and Yandell , D. W.Mutation spectrum of the p53 gene in bone and soft tissue sarcoma . Cancer Res. , 52 , 6194 – 6199 ( 1992. ). [PubMed] [Google Scholar]
  • 35. ) Kupryjanzyk , J. , Thor , A. N. , Beauchamp , R. , Merritt , V. , Edgerton , S. M. , Bell , D. A. and Yandell , D. W. , p53 gene mutations and protein accumulation in human ovarian cancer . Proc. Natl. Acad. Sci. USA , 90 , 4961 – 4965 ( 1993. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36. ) Lai , M. Y. , Chang , H. C. , Li , H. P. , Ku , C. K. , Chen , P. J. , Sheu , J. C. , Huang , G. T. , Lee , P. H. and Chen , D. S.Splicing mutations of the p53 gene in human hepatocel‐lular carcinoma . Cancer Res. , 53 , 1653 – 1656 ( 1993. ). [PubMed] [Google Scholar]
  • 37. ) Renault , B. , Van Den Broek , M. , Fodde , R. , Wijnen , J. , Pellegata , N. S. , Amadori , D. , Khan , P. M. and Ranzani , G. N.Base transitions are the most frequent genetic changes at p53 in gastric cancer . Cancer Res. , 53 , 2614 – 2617 ( 1993. ). [PubMed] [Google Scholar]
  • 38. ) Iggo , R. , Gatter , K. , Barter , J. , Lane , D. and Harris , A. L.Increased expression of mutant forms of p53 oncogene in primary lung cancer . Lancet , 335 , 675 – 679 ( 1990. ). [DOI] [PubMed] [Google Scholar]
  • 39. ) Shaulsky , G. , Goldfinger , N. , Ben‐ze'ev , A. and Rotter , V.Nuclear accumulation of p53 protein is mediated by several nuclear localization signals and plays a role in tumorigenesis . Mol. Cell. Biol. , 10 , 6565 – 6577 ( 1990. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40. ) Yanagisawa , A. , Ohtake , K. , Ohashi , K. , Hori , M. , Kitagawa , T. , Sugano , H. and Kato , Y.Frequent c‐Ki‐ras oncogene activation in mucous cell hyperplasias of pancreas suffering from chronic inflammation . Cancer Res. , 53 , 953 – 956 ( 1993. ). [PubMed] [Google Scholar]
  • 41. ) Pellegata , N. S. , Sessa , F. , Renault , B. , Bonato , M. , Leone , B. E. , Solcia , E. and Ranzani , G. N.K.‐ras and p53 mutations in pancreatic cancer: ductal and nonductal tumors progress through different genetic lesions . Cancer Res. , 54 , 1556 – 1560 ( 1994. ). [PubMed] [Google Scholar]

Articles from Japanese Journal of Cancer Research : Gann are provided here courtesy of Wiley

RESOURCES